[HTML][HTML] Daily treatment with SMTC1100, a novel small molecule utrophin upregulator, dramatically reduces the dystrophic symptoms in the mdx mouse
JM Tinsley, RJ Fairclough, R Storer, FJ Wilkes… - PloS one, 2011 - journals.plos.org
Background Duchenne muscular dystrophy (DMD) is a lethal, progressive muscle wasting
disease caused by a loss of sarcolemmal bound dystrophin, which results in the death of the …
disease caused by a loss of sarcolemmal bound dystrophin, which results in the death of the …
[PDF][PDF] Daily Treatment with SMTC1100, a Novel Small Molecule Utrophin Upregulator
JM Tinsley, RJ Fairclough, R Storer, FJ Wilkes… - 2011 - pdfs.semanticscholar.org
Background: Duchenne muscular dystrophy (DMD) is a lethal, progressive muscle wasting
disease caused by a loss of sarcolemmal bound dystrophin, which results in the death of the …
disease caused by a loss of sarcolemmal bound dystrophin, which results in the death of the …
[PDF][PDF] Daily Treatment with SMTC1100, a Novel Small Molecule Utrophin Upregulator
JM Tinsley, RJ Fairclough, R Storer, FJ Wilkes… - 2011 - scienceopen.com
Background: Duchenne muscular dystrophy (DMD) is a lethal, progressive muscle wasting
disease caused by a loss of sarcolemmal bound dystrophin, which results in the death of the …
disease caused by a loss of sarcolemmal bound dystrophin, which results in the death of the …
Daily Treatment with SMTC1100, a Novel Small Molecule Utrophin Upregulator, Dramatically Reduces the Dystrophic Symptoms in the mdx Mouse
JM Tinsley, RJ Fairclough, R Storer, FJ Wilkes… - PLoS ONE, 2011 - go.gale.com
Background Duchenne muscular dystrophy (DMD) is a lethal, progressive muscle wasting
disease caused by a loss of sarcolemmal bound dystrophin, which results in the death of the …
disease caused by a loss of sarcolemmal bound dystrophin, which results in the death of the …
[HTML][HTML] Daily Treatment with SMTC1100, a Novel Small Molecule Utrophin Upregulator, Dramatically Reduces the Dystrophic Symptoms in the mdx Mouse
JM Tinsley, RJ Fairclough, R Storer, FJ Wilkes… - PLoS ONE, 2011 - ncbi.nlm.nih.gov
Background Duchenne muscular dystrophy (DMD) is a lethal, progressive muscle wasting
disease caused by a loss of sarcolemmal bound dystrophin, which results in the death of the …
disease caused by a loss of sarcolemmal bound dystrophin, which results in the death of the …
Daily Treatment with SMTC1100, a Novel Small Molecule Utrophin Upregulator, Dramatically Reduces the Dystrophic Symptoms in the mdx Mouse.
JM Tinsley, RJ Fairclough, R Storer, FJ Wilkes… - PLoS …, 2011 - search.ebscohost.com
Background: Duchenne muscular dystrophy (DMD) is a lethal, progressive muscle wasting
disease caused by a loss of sarcolemmal bound dystrophin, which results in the death of the …
disease caused by a loss of sarcolemmal bound dystrophin, which results in the death of the …
Daily treatment with SMTC1100, a novel small molecule utrophin upregulator, dramatically reduces the dystrophic symptoms in the mdx mouse
JM Tinsley, RJ Fairclough, R Storer, FJ Wilkes… - PloS …, 2011 - pubmed.ncbi.nlm.nih.gov
Background Duchenne muscular dystrophy (DMD) is a lethal, progressive muscle wasting
disease caused by a loss of sarcolemmal bound dystrophin, which results in the death of the …
disease caused by a loss of sarcolemmal bound dystrophin, which results in the death of the …
Daily treatment with SMTC1100, a novel small molecule utrophin upregulator, dramatically reduces the dystrophic symptoms in the mdx mouse.
JM Tinsley, RJ Fairclough, R Storer, FJ Wilkes… - Plos one, 2011 - europepmc.org
Background Duchenne muscular dystrophy (DMD) is a lethal, progressive muscle wasting
disease caused by a loss of sarcolemmal bound dystrophin, which results in the death of the …
disease caused by a loss of sarcolemmal bound dystrophin, which results in the death of the …
[引用][C] Daily Treatment with SMTC1100, a Novel Small Molecule Utrophin Upregulator, Dramatically Reduces the Dystrophic Symptoms in the mdx Mouse
JM Tinsley, RJ Fairclough, R Storer, FJ Wilkes… - PLoS …, 2011 - ui.adsabs.harvard.edu
Daily Treatment with SMTC1100, a Novel Small Molecule Utrophin Upregulator, Dramatically
Reduces the Dystrophic Symptoms in the mdx Mouse - NASA/ADS Now on home page ads …
Reduces the Dystrophic Symptoms in the mdx Mouse - NASA/ADS Now on home page ads …
Daily treatment with SMTC1100, a novel small molecule utrophin upregulator, dramatically reduces the dystrophic symptoms in the mdx mouse
J Tinsley, R Fairclough, R Storer, F Wilkes, A Potter… - PLOS ONE, 2011 - ricerca.uniba.it
Background: Duchenne muscular dystrophy (DMD) is a lethal, progressive muscle wasting
disease caused by a loss of sarcolemmal bound dystrophin, which results in the death of the …
disease caused by a loss of sarcolemmal bound dystrophin, which results in the death of the …